Gene Report
Approved Symbol | ATM |
---|---|
Approved Name | ataxia telangiectasia mutated |
Previous Symbol | ATA, ATDC, ATC, ATD |
Previous Name | ataxia telangiectasia mutated (includes complementation groups A, C and D) |
Symbol Alias | TEL1, TELO1 |
Name Alias | TEL1, telomere maintenance 1, homolog (S. cerevisiae) |
Location | 11q22-q23 |
Position | chr11:108093559-108239826 (+) |
External Links |
Entrez Gene: 472 Ensembl: ENSG00000149311 UCSC: uc001pkb.1 HGNC ID: 795 |
No. of Studies (Positive/Negative) | 1(1/0) |
Type | Literature-origin |
Name in Literature | Reference | Research Type | Statistical Result | Relation Description | |
---|---|---|---|---|---|
ATM | Aston, 2005 | patients and normal controls | Genes altered in major depressive disorder Genes altered in major depressive disorder |
Network loading ...
Note:
1. The different color of the nodes denotes the level of the nodes.
Genetic/Epigenetic Locus | Protein and Other Molecule | Cell and Molecular Pathway | Neural System | Cognition and Behavior | Symptoms and Signs | Environment | MDD |
2. User can drag the nodes to rearrange the layout of the network. Click the node will enter the report page of the node. Right-click will show also the menus to link to the report page of the node and remove the node and related edges. Hover the node will show the level of the node and hover the edge will show the evidence/description of the edge.
3. The network is generated using Cytoscape Web
Approved Name | UniportKB | No. of Studies (Positive/Negative) | Source | |
---|---|---|---|---|
Serine-protein kinase ATM | Q13315 | 0(0/0) | Gene mapped |
Literature-origin GO terms | ||||
ID | Name | Type | Evidence | |
---|---|---|---|---|
GO:0032553 | ribonucleotide binding | molecular function | IEA | |
GO:0032553 | ribonucleotide binding | molecular function | IEA |
Gene mapped GO terms | ||||
ID | Name | Type | Evidence | |
---|---|---|---|---|
GO:0051402 | neuron apoptotic process | biological process | IEA | |
GO:0043525 | positive regulation of neuron apoptotic process | biological process | IEA | |
GO:0043065 | positive regulation of apoptotic process | biological process | IMP[17875758] | |
GO:0016023 | cytoplasmic membrane-bounded vesicle | cellular component | IEA | |
GO:0007420 | brain development | biological process | IEA | |
GO:0005515 | protein binding | molecular function | IPI | |
GO:0035174 | histone serine kinase activity | molecular function | IEA | |
GO:0007050 | cell cycle arrest | biological process | IMP[15149599] | |
GO:0004677 | DNA-dependent protein kinase activity | molecular function | IDA[15790808] | |
GO:0018105 | peptidyl-serine phosphorylation | biological process | IDA[9733515] | |
GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process | biological process | IMP[11375976] | |
GO:0043066 | negative regulation of apoptotic process | biological process | IEA | |
GO:0005654 | nucleoplasm | cellular component | TAS | |
GO:0007292 | female gamete generation | biological process | IEA | |
GO:0000723 | telomere maintenance | biological process | IEA | |
GO:0007507 | heart development | biological process | IEA | |
GO:0031572 | G2/M transition DNA damage checkpoint | biological process | IMP[15149599] | |
GO:0090399 | replicative senescence | biological process | IMP[15149599] | |
GO:0042159 | lipoprotein catabolic process | biological process | IEA | |
GO:0004674 | protein serine/threonine kinase activity | molecular function | IDA[9733515] | |
GO:0002331 | pre-B cell allelic exclusion | biological process | ISS | |
GO:0071480 | cellular response to gamma radiation | biological process | IDA[9925639] | |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | biological process | TAS | |
GO:0007165 | signal transduction | biological process | TAS[7792600] | |
GO:0006974 | response to DNA damage stimulus | biological process | IMP[15790808] | |
GO:0046777 | protein autophosphorylation | biological process | IDA[9733515] | |
GO:0006975 | DNA damage induced protein phosphorylation | biological process | IDA[9733515] | |
GO:0000075 | cell cycle checkpoint | biological process | TAS | |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | biological process | IMP[11943150] | |
GO:0046983 | protein dimerization activity | molecular function | IDA[15790808] | |
GO:0030889 | negative regulation of B cell proliferation | biological process | IMP[17875758] | |
GO:0006281 | DNA repair | biological process | TAS | |
GO:0001756 | somitogenesis | biological process | IEA | |
GO:0047485 | protein N-terminus binding | molecular function | IDA[11375976] | |
GO:0016303 | 1-phosphatidylinositol-3-kinase activity | molecular function | IMP[11375976] | |
GO:0005819 | spindle | cellular component | IEA | |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | biological process | IEA | |
GO:0032403 | protein complex binding | molecular function | IDA[15790808] | |
GO:0006302 | double-strand break repair | biological process | TAS | |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | biological process | IMP[9733515] | |
GO:0010212 | response to ionizing radiation | biological process | IDA[9733515] | |
GO:0071044 | histone mRNA catabolic process | biological process | IDA[16086026] | |
GO:0007131 | reciprocal meiotic recombination | biological process | TAS[7792600] | |
GO:0003677 | DNA binding | molecular function | IEA | |
GO:0005524 | ATP binding | molecular function | IEA | |
GO:0000724 | double-strand break repair via homologous recombination | biological process | TAS | |
GO:0001666 | response to hypoxia | biological process | IEA | |
GO:0000781 | chromosome, telomeric region | cellular component | IDA[15149599] |
Gene mapped KEGG pathways | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
hsa04210 | apoptosis | Apoptosis | Apoptosis is a genetically controlled mechanisms of cell dea...... Apoptosis is a genetically controlled mechanisms of cell death involved in the regulation of tissue homeostasis. The 2 major pathways of apoptosis are the extrinsic (Fas and other TNFR superfamily members and ligands) and the intrinsic (mitochondria-associated) pathways, both of which are found in the cytoplasm. The extrinsic pathway is triggered by death receptor engagement, which initiates a signaling cascade mediated by caspase-8 activation. Caspase-8 both feeds directly into caspase-3 activation and stimulates the release of cytochrome c by the mitochondria. Caspase-3 activation leads to the degradation of cellular proteins necessary to maintain cell survival and integrity. The intrinsic pathway occurs when various apoptotic stimuli trigger the release of cytochrome c from the mitochondria (independently of caspase-8 activation). Cytochrome c interacts with Apaf-1 and caspase-9 to promote the activation of caspase-3. Recent studies point to the ER as a third subcellular compartment implicated in apoptotic execution. Alterations in Ca2+ homeostasis and accumulation of misfolded proteins in the ER cause ER stress. Prolonged ER stress can result in the activation of BAD and/or caspase-12, and execute apoptosis. More... | |
hsa04115 | p53 signaling_pathway | p53 signaling pathway | p53 activation is induced by a number of stress signals, inc...... p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways. More... | |
hsa04110 | cell cycle | Cell cycle | Mitotic cell cycle progression is accomplished through a rep...... Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps known as G1 and G2 phases. Cyclin-dependent kinases (CDKs) are key regulatory enzymes, each consisting of a catalytic CDK subunit and an activating cyclin subunit. CDKs regulate the cell's progression through the phases of the cell cycle by modulating the activity of key substrates. Downstream targets of CDKs include transcription factor E2F and its regulator Rb. Precise activation and inactivation of CDKs at specific points in the cell cycle are required for orderly cell division. Cyclin-CDK inhibitors (CKIs), such as p16Ink4a, p15Ink4b, p27Kip1, and p21Cip1, are involved in the negative regulation of CDK activities, thus providing a pathway through which the cell cycle is negatively regulated. Eukaryotic cells respond to DNA damage by activating signaling pathways that promote cell cycle arrest and DNA repair. In response to DNA damage, the checkpoint kinase ATM phosphorylates and activates Chk2, which in turn directly phosphorylates and activates p53 tumor suppressor protein. p53 and its transcriptional targets play an important role in both G1 and G2 checkpoints. ATR-Chk1-mediated protein degradation of Cdc25A protein phosphatase is also a mechanism conferring intra-S-phase checkpoint activation. More... |
Literature-origin BioCarta pathway | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
G1_PATHWAY | g1 pathway | Cell Cycle: G1/S Check Point | The G1/S cell cycle checkpoint controls the passage of eukar...... The G1/S cell cycle checkpoint controls the passage of eukaryotic cells from the first 'gap' phase (G1) into the DNA synthesis phase (S). Two cell cycle kinases, CDK4/6-cyclin D and CDK2-cyclin E, and the transcription complex that includes Rb and E2F are pivotal in controlling this checkpoint. During G1 phase, the Rb-HDAC repressor complex binds to the E2F-DP1 transcription factors, inhibiting the downstream transcription. Phosphorylation of Rb by CDK4/6 and CDK2 dissociates the Rb-repressor complex, permitting transcription of S-phase genes encoding for proteins that amplify the G1 to S phase switch and that are required for DNA replication. Many different stimuli exert checkpoint control including TGFb, DNA damage, contact inhibition, replicative senescence, and growth factor withdrawal. The first four act by inducing members of the INK4 or Kip/Cip families of cell cycle kinase inhibitors. TGFb additionally inhibits the transcription of Cdc25A, a phosphatase that activates the cell cycle kinases. Growth factor withdrawal activates GSK3b, which phosphorylates cyclin D, leading to its rapid ubiquitination and proteosomal degradation. Ubiquitination, nuclear export, and degradation are mechanisms commonly used to rapidly reduce the concentration of cell-cycle control proteins. More... |
Gene mapped BioCarta pathways | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
ATM_PATHWAY | atm pathway | ATM Signaling Pathway | The ataxia telangiectasia-mutated gene (ATM) encodes a prote...... The ataxia telangiectasia-mutated gene (ATM) encodes a protein kinase that acts as a tumor suppressor. ATM activation by ionizing radiation damage to DNA stimulates DNA repair and blocks progression through the cell cycle. Mutation of the ATM gene causes the disease ataxia telangiectasia which which involves an inherited predisposition to some cancers. To play this role ATM interacts with a broad network of proteins, including checkpoint factors (chk1, chk2), tumor suppressors (p53 and BRCA), DNA repair factors (RAD50, RAD51, GADD45), and other signaling molecules (c-Abl and NF-kB). In addition to regulating DNA repair and the cell cycle, ATM can also trigger apoptosis in radiation treated cells. More... | |
G2_PATHWAY | g2 pathway | Cell Cycle: G2/M Checkpoint | The G2/M DNA damage checkpoint prevents the cell from enteri...... The G2/M DNA damage checkpoint prevents the cell from entering mitosis (M phase) if the genome is damaged. The Cdc2-cyclin B kinase is pivotal in regulating this transition. During G2 phase, Cdc2 is maintained in an inactive state by the kinases Wee1 and Mt1. As cells approach M phase, the phosphatase Cdc25 is activated, perhaps by the polo-kinase Pik1. Cdc25 then activates Cdc2, establishing a feedback amplification loop that efficiently drives the cell into mitosis. DNA damage activates the DNA-PK/ATM/ATR kinases, initiating two parallel cascades that inactivate Cdc2-cyclin B. The first cascade rapidly inhibits progression into mitosis: the CHK kinases phosphorylate and inactivate Cdc25, which can no longer activate Cdc2. The second cascade is slower. Phosphorylation of p53 dissociates it from MDM2, activating its DNA binding activity. Acetylation by p300/PCAF further activates its transcriptional activity. The genes that are turned on by p53 constitute effectors of this second cascade. They include 14-3-3s, which binds to the phosphorylated Cdc2-cyclin B kinase and exports it from the nucleus; GADD45, which apparently binds to and dissociates the Cdc2-cyclin B kinase; and p21Cip1, an inhibitor of a subset of the cyclin-dependent kinases including Cdc2 (CDK1). More... | |
ATRBRCA_PATHWAY | atrbrca pathway | Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility | BRCA1 and BRCA2 were identified genetically as breast cancer...... BRCA1 and BRCA2 were identified genetically as breast cancer susceptibility genes when a single copy of the gene is mutated and are involved in the cellular response to DNA damage, including blocking cell cycle progression and inducing DNA repair to preserve the integrity of the genome during cell division. BRCA1 and BRCA2 induce double-stranded repair of breaks using homologous recombination, in part through activation of RAD51. BRCA1 acts as a ubiquitin ligase targeting the protein FancD2 that activates checkpoint control, integrating the ATM response to ionizing radiation and the FA response to cross-linking agents like mitomycin C. Mutation of one of the several components of the FA complex involved in maintaining integrity of the genome leads to the condition Fanconi anemia. One member of the FA complex was recently identified as BRCA2, which leads to Fanconi anemia when both copies of the gene are mutated. Another related factor involved in the response of cells to DNA damage is the kinase ATM. ATM is mutated in patients with AT, a condition with many similar traits to Fanconi anemia. Like ATM, ATR serves as a checkpoint kinase that halts cell cycle progression and induces DNA repair when DNA is damaged. Loss of ATR results in a loss of checkpoint control in response to DNA damage, leading to cell death, and deletion of the ATR gene in mice is embryonic lethal. ATRIP is a protein that interacts with ATR and is a substrate for its kinase activity. ATRIP is required for ATR function, and removal of ATRIP also leads to a loss of checkpoint control of the cell cycle. ATR and ATM kinase targets include repair enzymes like Rad51, and the checkpoint kinases Chk1 and Chk2, as well as BRCA1 and BRCA2. The close relationship of the genes involved in breast cancer and Fanconi anemia has helped illuminate this signaling system, and may help lead to improved understanding and treatment of these conditions. More... | |
P53HYPOXIA_PATHWAY | p53hypoxia pathway | Hypoxia and p53 in the Cardiovascular system | Hypoxic stress, like DNA damage, induces p53 protein accumul...... Hypoxic stress, like DNA damage, induces p53 protein accumulation and p53-dependent apoptosis in oncogenically transformed cells. Unlike DNA damage, hypoxia does not induce p53-dependent cell cycle arrest, suggesting that p53 activity is differentially regulated by these two stresses. Hypoxia induces p53 protein accumulation, but in contrast to DNA damage, hypoxia fails to induce endogenous downstream p53 effector mRNAs and proteins, such as p21, Bax, CIP1, WAF1 etc. Hypoxia does not inhibit the induction of p53 target genes by ionizing radiation, indicating that p53-dependent transactivation requires a DNA damage-inducible signal that is lacking under hypoxic treatment alone. The phosphatidylinositol 3-OH-kinase-Akt pathway inhibits p53-mediated transcription and apoptosis. Mdm2, a ubiquitin ligase for p53, plays a central role in regulation of the stability of p53 and serves as a good substrate for Akt. Mdm-2 targets the p53 tumor suppressor for ubiquitin-dependent degradation by the proteasome, but, in addition, the p53 transcription factor induces Mdm-2, thus, establishing a feedback loop. Hypoxia or DNA damage by abrogating binding of HIF-1 with VHL and p53 with Mdm-2, respectively, leads to stabilization and accumulation transcriptionally active HIF-1 and p53. At the molecular level, DNA damage induces the interaction of p53 with the transcriptional activator p300 as well as with the transcriptional corepressor mSin3A. In contrast, hypoxia primarily induces an interaction of p53 with mSin3A, but not with p300. More... | |
RB_PATHWAY | rb pathway | RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage | Cell cycle checkpoint controls at the G1 to S transition and...... Cell cycle checkpoint controls at the G1 to S transition and the G2 to M transition prevent the cell cycle from progressing when DNA is damaged. The ATM protein kinase detects DNA damage and in response to this activates DNA repair factors and inhibits cell cycle progression. Two of the proteins that ATM phosphorylates in response to DNA damage are the tumor suppressor p53 and the checkpoint kinase chk1. In turn, the tumor suppressor p53 interacts with p21 to block the activity of cdk2 (cyclin dependent kinase 2) preventing passage from G1 to S phase and harmful replication of damaged DNA. One of the targets of cdk2 is the Rb gene product, another tumor suppressor. When dephosphorylated, Rb interacts with E2F transcription factors and prevents transcription of genes required for progression through the cell cycle. When phosphorylated by cell cycle dependent kinases like cdk2 and cdk4, Rb no longer interacts with E2F and the cell cycle proceeds through the G1-S checkpoint. DNA damage also regulates the G2-M phase transition by acting on the cell cycle regulator cdc2. More... | |
CHEMICAL_PATHWAY | chemical pathway | Apoptotic Signaling in Response to DNA Damage | The cellular activation of the caspase cascade resulting in ...... The cellular activation of the caspase cascade resulting in cell death is triggered by chemical damage to DNA which stimulates a sequence resulting in the cleavage of Bid in a manner similar to the binding of so called death-receptors or directly initiates the permeability transition of the mitochondrial membrane. The permiability transition releases several factors including cytochrome c, AIF and other factors in to the cytoplasm. Cytochrome c, a key protein in electron transport, is released from mitochondria in response to apoptotic signals, and activates Apaf-1, a protease released from mitochondria. Activated Apaf-1 activates caspase-9 and the rest of the caspase cascade. The caspases are a class of cysteine proteases that includes several representatives involved in apoptosis. The caspases convey the apoptotic signal in a proteolytic cascade, with caspases cleaving and activating other caspases that then degrade other cellular targets that lead to cell death. More... | |
P53_PATHWAY | p53 pathway | p53 Signaling Pathway | p53 is a transcription factor who's activity is regulated by...... p53 is a transcription factor who's activity is regulated by phosphorylation. The function is p53 is to keep the cell from progressing through the cell cycle if there is damage to DNA present. It may do this in multiple ways from holding the cell at a checkpoint until repairs can be made to causing the cell to enter apoptosis if the damage cannot be repaired. The critical role of p53 is evidenced by the fact that it is mutated in a very large fraction of tumors from nearly all sources. More... |
Gene mapped Reactome pathways | |||
ID | Name | Description | |
---|---|---|---|
REACT_1538 | cell cycle_checkpoints | A hallmark of the human cell cycle in normal somatic cells i...... A hallmark of the human cell cycle in normal somatic cells is its precision. This remarkable fidelity is achieved by a number of signal transduction pathways, known as checkpoints, which monitor cell cycle progression ensuring an interdependency of S-phase and mitosis, the integrity of the genome and the fidelity of chromosome segregation. Checkpoints are layers of control that act to delay CDK activation when defects in the division program occur. As the CDKs functioning at different points in the cell cycle are regulated by different means, the various checkpoints differ in the biochemical mechanisms by which they elicit their effect. However, all checkpoints share a common hierarchy of a sensor, signal transducers, and effectors that interact with the CDKs. The stability of the genome in somatic cells contrasts to the almost universal genomic instability of tumor cells. There are a number of documented genetic lesions in checkpoint genes, or in cell cycle genes themselves, which result either directly in cancer or in a predisposition to certain cancer types. Indeed, restraint over cell cycle progression and failure to monitor genome integrity are likely prerequisites for the molecular evolution required for the development of a tumor. Perhaps most notable amongst these is the p53 tumor suppressor gene, which is mutated in >50% of human tumors. Thus, the importance of the checkpoint pathways to human biology is clear. More... | |
REACT_309 | stabilization of_p53 | Later studies pin-pointed that a single serine. ATM also reg...... Later studies pin-pointed that a single serine. ATM also regulates the phosphorylation of p53 at other sites, especially Ser-20, by activating other serine/threonine kinases in response to IR. Phosphorylation of p53 at Ser-20 interferes with p53-MDM2 interaction. MDM2 is transcriptionally activated by p53 and is a negative regulator of p53 that targets it for degradation. In addition modification of MDM2 by ATM also affects p53 stabilization. More... | |
REACT_828 | g2 m_checkpoints | G2/M checkpoints include the checks for damaged DNA, unrepli...... G2/M checkpoints include the checks for damaged DNA, unreplicated DNA, and checks that ensure that the genome is replicated once and only once per cell cycle. If cells pass these checkpoints, they follow normal transition to the M phase. However, if any of these checkpoints fail, mitotic entry is prevented by specific G2/M checkpoint events. The G2/M checkpoints can fail due to the presence of unreplicated DNA or damaged DNA. In such instances, the cyclin-dependent kinase, Cdc2(Cdk1), is maintained in its inactive, phosphorylated state, and mitotic entry is prevented. Events that ensure that origins of DNA replication fire once and only once per cell cycle are also an example of a G2/M checkpoint. In the event of high levels of DNA damage, the cells may also be directed to undergo apopotosis (not covered). More... | |
REACT_2054 | double strand_break_repair | Numerous types of DNA damage can occur within a cell due to ...... Numerous types of DNA damage can occur within a cell due to the endogenous production of oxygen free radicals, normal alkylation reactions, or exposure to exogenous radiations and chemicals. Double-strand breaks. HRR functions primarily in repairing both one-sided DSBs that arise at DNA replication forks and two-sided DSBs arising in S or G2-phase chromatid regions that have replicated. More... | |
REACT_216 | dna repair | DNA repair is a phenomenal multi-enzyme, multi-pathway syste...... DNA repair is a phenomenal multi-enzyme, multi-pathway system required to ensure the integrity of the cellular genome. These cellular mechanisms that must cope with the plethora of DNA base pair adducts that arise. DNA damage can arise spontaneously in the cellular milieu through chemical alteration of base nucleotides or as a consequence of errors during DNA replication. For example, it is well known that normal cellular pH and temperature offer an environment, which is hostile to the integrity of DNA and its nucleotide components. Additionally, DNA damage may be induced in response to environmental exposures, including exposure to physical agents such as ionizing or ultraviolet (UV) radiation. Finally, specific chemical agents are known to alkylate or cross-link DNA bases, produce bulky adducts on DNA bases, or break DNA phosphate-sugar backbone. The pioneering work from a number of laboratories have elucidated the basic mechanisms underlying distinct DNA repair pathways that include nucleotide excision repair (NER), base excision repair (BER), DNA strand break repair (DSBR), direct reversal of DNA damage, and the replication past DNA lesions by specialized DNA bypass polymerases (bypass replication). Defects in most of these repair pathways have been associated with one or more specific human diseases. Additionally, the repair of damaged DNA is intimately associated with a number of other distinct cellular processes such as DNA replication, DNA recombination, cell cycle checkpoint arrest, and other basic cellular mechanisms as outlined herein. More... | |
REACT_1874 | homologous recombination_repair | The HRR pathway is an error free DNA repair mechanism that u...... The HRR pathway is an error free DNA repair mechanism that utilizes information encoded by homologous sequence to repair double-strand breaks (DSBs). HRR acts on DSBs occurring within replicated DNA (replication-independent DSBs) or on DSBs that are generated at broken replication forks (replication-dependent DSBs). Repair by homologous recombination involves processing of the ends of the DNA double-strand break, homologous DNA pairing and strand exchange, repair DNA synthesis, and resolution of the heteroduplex molecules. More... |
ATM related interactors from protein-protein interaction data in HPRD (count: 40)
Gene | Interactor | Interactor in MK4MDD? | Experiment Type | PMID | |
---|---|---|---|---|---|
ATM | STK11 | No | in vitro;in vivo | 11853558 , 12234250 | |
ATM | CHEK1 | No | in vitro;in vivo | 11390642 , 11252893 | |
ATM | E2F1 | No | in vitro | 11459832 | |
ATM | RAD9A | No | in vitro;in vivo | 12709442 , 11278446 | |
ATM | XRCC5 | No | in vivo | 15758953 | |
ATM | PRKDC | No | in vitro | 10464290 | |
ATM | MDM2 | No | in vitro;in vivo | 11331603 | |
ATM | TP53BP1 | No | in vitro;in vivo | 12697768 | |
ATM | TP53 | No | in vitro;in vivo | 9765199 , 11551930 , 11709713 , 10673501 , 11875057 , 16858402 , 17157788 , 9843217 | |
ATM | RAD51 | No | in vitro;in vivo | 10212258 | |
ATM | EIF4EBP1 | No | in vitro;in vivo | 9806882 , 11146653 , 12588975 | |
ATM | FANCD2 | No | in vitro;in vivo | 12086603 | |
ATM | TERF1 | No | in vitro;in vivo | 11375976 , 15314656 | |
ATM | EEF1E1 | Yes | in vitro;in vivo | 15680327 | |
ATM | AP1B1 | No | in vitro;in vivo;yeast 2-hybrid | 9707615 | |
ATM | CHEK2 | No | in vivo | 11901158 , 12242661 , 10973490 , 12493754 , 16794575 | |
ATM | AP3B2 | No | in vitro;yeast 2-hybrid | 9707615 | |
ATM | H2AFX | No | in vivo | 9488723 , 11893489 , 11571274 | |
ATM | AATF | No | in vitro;in vivo | 17157788 | |
ATM | SMC1A | No | in vitro;in vivo | 11877377 | |
ATM | RHEB | No | in vitro | 15854902 | |
ATM | MRE11A | No | in vitro | 10608806 | |
ATM | RAD17 | No | in vitro;in vivo | 11418864 , 10608806 | |
ATM | BRCA1 | No | in vitro;in vivo | 10550055 , 10866324 , 11114888 | |
ATM | CREB1 | Yes | in vitro | 16293623 , 15073328 | |
ATM | ABL1 | No | in vitro;in vivo;yeast 2-hybrid | 9168117 , 9168116 | |
ATM | ATM | Yes | in vitro;in vivo | 14519663 , 12556884 , 10608806 , 16858402 , 16906133 | |
ATM | DCLRE1C | No | in vitro;in vivo | 15456891 | |
ATM | TIPARP | No | in vivo | 11238919 | |
ATM | TOPBP1 | No | in vitro;in vivo | 11756551 | |
ATM | AP2B1 | No | in vitro;in vivo;yeast 2-hybrid | 9707615 | |
ATM | NBN | No | in vitro;in vivo | 10839544 , 11252893 , 10839545 , 10608806 | |
ATM | WRN | No | in vitro | 10608806 , 11252893 , 10839545 | |
ATM | RBBP8 | No | in vitro;in vivo | 10910365 , 11689934 | |
ATM | MDC1 | No | in vivo | 12607005 | |
ATM | KAT5 | Yes | in vitro;in vivo | 16141325 | |
ATM | TREX1 | No | in vivo | 15758953 | |
ATM | PEX5 | No | in vivo;yeast 2-hybrid | 10567403 | |
ATM | MDM4 | No | in vitro;in vivo | 15788536 , 16163388 | |
ATM | XPA | No | in vitro | 16540648 |